Efthymia Vokali

401 total citations
6 papers, 166 citations indexed

About

Efthymia Vokali is a scholar working on Neurology, Pharmacology and Physiology. According to data from OpenAlex, Efthymia Vokali has authored 6 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 2 papers in Pharmacology and 2 papers in Physiology. Recurrent topics in Efthymia Vokali's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Efthymia Vokali is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Efthymia Vokali collaborates with scholars based in Sweden, Belgium and Denmark. Efthymia Vokali's co-authors include Andrea Pfeifer, Heiko Kroth, Francesca Capotosti, Jérôme Molette, Andreas Muhs, David T. Hickman, Hanno Schieferstein, André Mueller, Emanuele Gabellieri and Andrew Stephens and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging and Alzheimer s & Dementia.

In The Last Decade

Efthymia Vokali

6 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Efthymia Vokali Sweden	5	113	57	47	46	36	6	166
Jérôme Molette Switzerland	8	139 1.2×	58 1.0×	52 1.1×	57 1.2×	61 1.7×	15	279
Jonathan Vöglein Germany	9	95 0.8×	29 0.5×	40 0.9×	46 1.0×	40 1.1×	19	216
Yvan Varisco Switzerland	6	161 1.4×	35 0.6×	44 0.9×	40 0.9×	53 1.5×	7	230
Hironobu Endo Japan	10	138 1.2×	101 1.8×	57 1.2×	67 1.5×	44 1.2×	28	268
Paul T. Manser United States	9	186 1.6×	36 0.6×	38 0.8×	37 0.8×	45 1.3×	22	262
Erin Franklin United States	7	173 1.5×	54 0.9×	21 0.4×	39 0.8×	56 1.6×	13	238
Felix Overhoff Germany	6	140 1.2×	25 0.4×	40 0.9×	53 1.2×	53 1.5×	8	249
Federico Probst Germany	6	140 1.2×	25 0.4×	40 0.9×	53 1.2×	53 1.5×	8	249
Julia Remnestål Sweden	7	112 1.0×	37 0.6×	14 0.3×	25 0.5×	83 2.3×	9	188
Dawn Matthews United States	7	96 0.8×	18 0.3×	47 1.0×	45 1.0×	68 1.9×	11	260

Countries citing papers authored by Efthymia Vokali

Since Specialization

Citations

This map shows the geographic impact of Efthymia Vokali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efthymia Vokali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efthymia Vokali more than expected).

Fields of papers citing papers by Efthymia Vokali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efthymia Vokali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efthymia Vokali. The network helps show where Efthymia Vokali may publish in the future.

Co-authorship network of co-authors of Efthymia Vokali

This figure shows the co-authorship network connecting the top 25 collaborators of Efthymia Vokali. A scholar is included among the top collaborators of Efthymia Vokali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efthymia Vokali. Efthymia Vokali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Seredenina, Tamara, Efthymia Vokali, Tariq Afroz, et al.. (2023). Discovery and optimization of the first‐in‐class TDP‐43 PET tracer. Alzheimer s & Dementia. 19(S13). 8 indexed citations

2.

Smith, Ruben, Francesca Capotosti, Martin Schain, et al.. (2022). Initial clinical scans using [¹⁸F]ACI‐12589, a novel α‐synuclein PET‐tracer. Alzheimer s & Dementia. 18(S6). 8 indexed citations

3.

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2022). Discovery of [¹⁸F]ACI‐12589, a Novel and Promising PET‐Tracer for Alpha‐Synuclein. Alzheimer s & Dementia. 18(S6). 4 indexed citations

4.

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2021). The development of [¹⁸F]ACI‐12589, a high affinity and selective alpha‐synuclein radiotracer, as a biomarker for Parkinson’s disease and other synucleinopathies. Alzheimer s & Dementia. 17(S5). 7 indexed citations

5.

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2020). Developing a novel alpha‐synuclein positron emission tomography (PET) tracer for the diagnosis of synucleinopathies. Alzheimer s & Dementia. 16(S5). 5 indexed citations

6.

Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2019). Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2178–2189. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact